Shenyang Xingqi Pharmaceutical News and Activities

Shenyang Xingqi Pharmaceutical is a company listed under the stock ticker 300573 (CN).

View the org chart displaying its 9 main executives

Most searched biographies at Shenyang Xingqi Pharmaceutical

• E Gao, General Manager and Director
• Chunhua Li, Director
• Jidong Liu, Chairman of the Board

Create your alert
to follow the executive moves at Shenyang Xingqi Pharmaceutical.

Shenyang Xingqi Pharmaceutical has 1,914 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Aurobindo has announced the acquisition of Lannett  (posted on June 26 2026).
• Merck has announced the acquisition of Bio-Techne  (posted on June 25 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• David Ricks - President, Chief Executive Officer and Chairman of the Board at Eli Lilly
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Shenyang Xingqi Pharmaceutical

• 分享到QQ空间
• COMPANY NEWS-SINQI
• COMPANY EVENTS-SINQI

Social media about Shenyang Xingqi Pharmaceutical

• Shenyang Xingqi Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Shenyang Xingqi Pharmaceutical on LinkedIn, X (Twitter) & YouTube